In hepatocellular carcinoma, the inhibition of EZH2 by small-molecule or genetic inhibitors can enhance HCC cell eradication by NK cells in an NK group 2D (NKG2D) ligand-dependent manner [16]. Here, EZH2 is linked to hepatocellular carcinoma.